Are you Dr. Hibberd?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 59 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
725 Albany St Ste 9b C
Shapiro Bldg
Boston, MA 02118Phone+1 617-414-4290Fax+1 617-414-4285
Summary
- Dr. Patricia Hibberd, MD is an infectious disease specialist in Boston, Massachusetts. She is currently licensed to practice medicine in Massachusetts. She is affiliated with Boston Medical Center and is a Lecturer at Tufts Medical Center.
Education & Training
Massachusetts General HospitalResidency, Internal Medicine, 1986 - 1992
Harvard Medical SchoolClass of 1986
Certifications & Licensure
MA State Medical License 1988 - 2025
Clinical Trials
- Probiotics to Enhance Immunogenicity of Influenza Vaccine in Healthy Adults Start of enrollment: 2007 Sep 01
- Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers Start of enrollment: 2009 Dec 01
- Maternal Newborn Health Registry Start of enrollment: 2008 May 01
- Join now to see all
Publications & Presentations
PubMed
- 40 citationsRandomized controlled trial of 4 compared with 6 mo of exclusive breastfeeding in Iceland: differences in breast-milk intake by stable-isotope probeJonathan C. K. Wells, Olof H Jonsdottir, Patricia L. Hibberd, Mary Fewtrell, Inga Thorsdottir
The American Journal of Clinical Nutrition. 2012-07-01 - 25 citationsExclusive breastfeeding for 4 versus 6 months and growth in early childhoodOlof H Jonsdottir, Ronald E. Kleinman, Jonathan C. K. Wells, Mary Fewtrell, Patricia L. Hibberd
Acta Paediatrica. 2014-01-01 - 61 citationsMaternal anaemia and maternal, fetal, and neonatal outcomes in a prospective cohort study in India and Pakistan.Stefanie Parks, Matthew K. Hoffman, Shivaprasad S. Goudar, Archana Patel, Sarah Saleem
BJOG. 2019-05-01
Press Mentions
When 'Friendly' Probiotic Bacteria Turn into Foes in the ICUNovember 29th, 2019
AixSwiss Delivers Transparency with Unique QR Code That Shows Lab Results for Nupure ProbiflorSeptember 18th, 2018
Safety of Probiotic Supplements Is Not Guaranteed, Study SaysJuly 16th, 2018- Join now to see all
Grant Support
- Improving Quality Of Care For The Treatment Of Childhood PneumoniaEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2012
- Probiotics To Enhance Influenza Vaccine ImmunogenicityNational Center For Complementary &Alternative Medicine2010–2011
- Midcareer Investigator Award In Patient-Oriented Research (K24)National Center For Complementary &Alternative Medicine2010–2011
- Probiotics To Eradicate Nasal S Aureus In ESRD PatientsNational Center For Complementary &Alternative Medicine2005–2011
- Effects Of Probiotics In Patients With Cystic FibrosisNational Center For Complementary &Alternative Medicine2010
- Improving Quality Of Care For The Treatment Of Childhood PneumoniaEunice Kennedy Shriver National Institute Of Child Health &Human Development2008–2009
- Midcareer Investigator Award In Patient-Oriented Research (K24)National Center For Complementary &Alternative Medicine2006–2009
- Effects Of Probiotics In Patients With Cystic FibrosisNational Center For Complementary &Alternative Medicine2006–2009
- Developing Probiotics As Foods And Drugs - Scientific And Regulatory ChallengesNational Center For Complementary &Alternative Medicine2006
- Open-Label, Dose Escalation Phase 1 Study To Eval Clostrodium Difficile Toxin ANational Center For Research Resources2005
- Effects Of Probiotics In Patients With Cystic FibrosisNational Center For Complementary &Alternative Medicine2004–2005
- Probiotics To Eradicate Nasal S Aureus In ESRD PatientsNational Center For Complementary &Alternative Medicine2004
